Baader Katharina, Hiller Karl-Anton, Buchalla Wolfgang, Schmalz Gottfried, Federlin Marianne
J Adhes Dent. 2016;18(1):69-79. doi: 10.3290/j.jad.a35549.
To investigate the influence of selective enamel etching on long-term clinical performance of partial ceramic crowns (PCCs) luted with a self-adhesive luting material (RXU: RelyX Unicem).
At baseline, 34 patients received the intended treatment: two PCCs (Vita Mark II; Cerec 3D) for the restoration of extended lesions with multiple-cusp coverage were placed in a split-mouth design with a self-adhesive luting material, one without (RXU) and one with selective enamel etching (RXU+E). Patients were evaluated clinically (modified USPHS criteria) at baseline and up to 6.5 years (70 to 88 months). The chi-square test was used for statistical analyses (α=0.05). Clinical survival of all restorations (n=68) after 6.5 years was evaluated by Kaplan-Meier analysis.
After 6.5 years, 18 patients (9 male, 9 female; median age 41, range 25 to 59 years) with 36 RXU and RXU+E restorations were available for clinical assessment (patient recall rate: 53%), with 13 RXU and 14 RXU+E PCCs placed in molars and 5 RXU and 4 RXU+E PCCs in premolars. Clinically, no statistically significant differences between the luting procedures were detected. Both RXU and RXU+E revealed significant changes over time with respect to marginal adaptation (significant deterioration) and marginal discoloration (significant increase). RXU revealed no cases of postoperative hypersensitivity and RXU+E only did so at baseline (n=5). Kaplan-Meier analysis showed a cumulative survival for RXU of 60% and for RXU+E of 82%, indicating a significantly higher survival rate for RXU+E.
Clinically, RXU and RXU+E perform similarly. In PCC restorations with multiple-cusp coverage, lack of retention due to adhesive preparation, and little dentin available for adhesion caused by extensive core buildups or cavity linings, selective enamel etching is recommended.
探讨选择性釉质酸蚀对使用自粘结粘结材料(RXU:RelyX Unicem)粘结的部分陶瓷冠(PCC)长期临床性能的影响。
在基线时,34例患者接受了预期治疗:采用自粘结粘结材料,以分口设计放置两颗用于修复多尖覆盖的扩展型病变的PCC(Vita Mark II;Cerec 3D),一颗未进行选择性釉质酸蚀(RXU),另一颗进行了选择性釉质酸蚀(RXU+E)。在基线时以及长达6.5年(70至88个月)对患者进行临床评估(采用改良的美国公共卫生服务标准)。采用卡方检验进行统计分析(α=0.05)。通过Kaplan-Meier分析评估6.5年后所有修复体(n=68)的临床生存率。
6.5年后,18例患者(9例男性,9例女性;中位年龄41岁,范围25至59岁)的36个RXU和RXU+E修复体可供临床评估(患者召回率:53%),其中13个RXU和14个RXU+E PCC放置在磨牙,5个RXU和4个RXU+E PCC放置在前磨牙。临床上,未检测到粘结程序之间有统计学显著差异。RXU和RXU+E在边缘适应性(显著恶化)和边缘变色(显著增加)方面均随时间有显著变化。RXU未出现术后过敏病例,RXU+E仅在基线时有5例出现术后过敏。Kaplan-Meier分析显示RXU的累积生存率为60%,RXU+E为82%,表明RXU+E的生存率显著更高。
临床上,RXU和RXU+E表现相似。在多尖覆盖的PCC修复中,由于粘结预备导致固位不足,以及广泛的核修复或洞衬导致可供粘结的牙本质较少,建议进行选择性釉质酸蚀。